Literature DB >> 3431821

Neodymium: YAG transscleral cyclocoagulation in human eyes.

R G Devenyi1, G E Trope, W H Hunter, O Badeeb.   

Abstract

Transscleral neodymium: YAG (Nd:YAG) cyclocoagulation has been successfully used to lower intraocular pressure (IOP) in rabbits. The authors treated 24 patients with uncontrolled glaucoma using the thermal mode of the Nd:YAG laser. The patients were followed for a mean of 8.8 months. A total of 62.5% of treated eyes achieved an IOP on last follow-up of 25 mmHg or less. The mean pretreatment pressure was 47.2 mmHg and the mean posttreatment pressure was 25.7 mmHg (P = 0.009). The complications and potential clinical usefulness of this mode of therapy are discussed.

Entities:  

Mesh:

Year:  1987        PMID: 3431821     DOI: 10.1016/s0161-6420(87)33252-x

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  Transscleral Nd: YAG laser cyclophotocoagulation versus cyclocryotherapy.

Authors:  Y Suzuki; M Araie; A Yumita; T Yamamoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

2.  Histopathologic observations on human eyes following neodymium: YAG laser cyclophotocoagulation for glaucoma.

Authors:  A P Ferry; M H King; D W Richards
Journal:  Trans Am Ophthalmol Soc       Date:  1995

3.  Transvitreal endocyclophotocoagulation.

Authors:  J A Haller
Journal:  Trans Am Ophthalmol Soc       Date:  1996

4.  A comparison between tube surgery, ND:YAG laser and diode laser cyclophotocoagulation in the management of refractory glaucoma.

Authors:  Philip A Bloom; Colin I Clement; Anthony King; Baha Noureddin; Kamal Sharma; Roger A Hitchings; Peng T Khaw
Journal:  Biomed Res Int       Date:  2013-10-07       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.